Minralys Starts 2nd Pivotal Trial of Lorundrostat for Hypertension

 – Topline data from confirmatory Launch-HTN trial expected in 2H 2025 –

– Topline data from ongoing Advance-HTN pivotal trial expected in 2H 2024 –

https://www.globenewswire.com/news-release/2023/12/21/2800342/0/en/Mineralys-Therapeutics-Announces-First-Subject-Dosed-in-Launch-HTN-the-Second-Pivotal-Trial-of-Lorundrostat-for-the-Treatment-of-Hypertension.html